- Report
- October 2025
- 147 Pages
Global
From €2275EUR$2,549USD£2,006GBP
€2676EUR$2,999USD£2,360GBP
- Report
- September 2025
- 141 Pages
Global
From €2275EUR$2,549USD£2,006GBP
€2676EUR$2,999USD£2,360GBP
- Report
- August 2025
- 136 Pages
Global
From €2275EUR$2,549USD£2,006GBP
€2676EUR$2,999USD£2,360GBP
- Report
- May 2025
- 139 Pages
Global
From €2275EUR$2,549USD£2,006GBP
€2676EUR$2,999USD£2,360GBP
- Report
- April 2025
- 146 Pages
Global
From €2275EUR$2,549USD£2,006GBP
€2676EUR$2,999USD£2,360GBP
- Report
- January 2025
- 125 Pages
Global
From €2275EUR$2,549USD£2,006GBP
€2676EUR$2,999USD£2,360GBP
- Report
- June 2025
- 183 Pages
Global
From €4015EUR$4,500USD£3,540GBP
- Report
- June 2025
- 180 Pages
Global
From €4015EUR$4,500USD£3,540GBP
- Report
- June 2025
- 185 Pages
Global
From €4015EUR$4,500USD£3,540GBP
- Report
- May 2025
- 185 Pages
Global
From €4015EUR$4,500USD£3,540GBP
- Report
- May 2025
- 190 Pages
Global
From €4015EUR$4,500USD£3,540GBP
- Report
- January 2025
- 182 Pages
Global
From €4015EUR$4,500USD£3,540GBP
- Report
- November 2024
- 159 Pages
Global
From €2231EUR$2,500USD£1,967GBP
- Report
- August 2025
- 150 Pages
Global
From €2996EUR$3,358USD£2,642GBP
€3524EUR$3,950USD£3,108GBP
- Report
- October 2025
- 150 Pages
Global
From €2543EUR$2,850USD£2,242GBP
€3435EUR$3,850USD£3,029GBP
- Report
- October 2025
- 150 Pages
Global
From €3435EUR$3,850USD£3,029GBP
- Report
- October 2025
- 150 Pages
Global
From €3435EUR$3,850USD£3,029GBP
- Report
- September 2025
- 150 Pages
Global
From €2543EUR$2,850USD£2,242GBP
€3435EUR$3,850USD£3,029GBP
- Report
- September 2025
- 150 Pages
Global
From €3435EUR$3,850USD£3,029GBP
- Report
- September 2025
- 150 Pages
Global
From €3435EUR$3,850USD£3,029GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more